blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3411365

EP3411365 - PYRAZOL-PYRIDINE DERIVATIVES AS EAAT3 INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.09.2020
Database last updated on 06.07.2024
FormerThe patent has been granted
Status updated on  18.10.2019
FormerGrant of patent is intended
Status updated on  25.06.2019
FormerRequest for examination was made
Status updated on  09.11.2018
FormerThe international publication has been made
Status updated on  11.08.2017
Formerunknown
Status updated on  13.02.2017
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2018/50]
Inventor(s)01 / WICHMANN, Juergen
c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
02 / HOENER, Marius
c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
 [2018/50]
Representative(s)Salud, Carlos E.
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2018/50]
Application number, filing date17702832.130.01.2017
[2018/50]
WO2017EP51873
Priority number, dateEP2016015374102.02.2016         Original published format: EP 16153741
[2018/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017133990
Date:10.08.2017
Language:EN
[2017/32]
Type: A1 Application with search report 
No.:EP3411365
Date:12.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 10.08.2017 takes the place of the publication of the European patent application.
[2018/50]
Type: B1 Patent specification 
No.:EP3411365
Date:20.11.2019
Language:EN
[2019/47]
Search report(s)International search report - published on:EP10.08.2017
ClassificationIPC:C07D401/04, C07D409/14, A61K31/4439, A61P25/00
[2018/50]
CPC:
C07D401/04 (EP,US); A61P25/00 (EP); A61P25/18 (EP);
A61P43/00 (EP); C07D409/14 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/50]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:PYRAZOLPYRIDINDERIVATE ALS EAAT3-HEMMER[2018/50]
English:PYRAZOL-PYRIDINE DERIVATIVES AS EAAT3 INHIBITORS[2018/50]
French:DÉRIVÉS PYRAZOL-PYRIDINE UTILISÉS COMME INHIBITEURS D'EAAT3[2018/50]
Entry into regional phase03.09.2018National basic fee paid 
03.09.2018Designation fee(s) paid 
03.09.2018Examination fee paid 
Examination procedure03.09.2018Examination requested  [2018/50]
03.09.2018Date on which the examining division has become responsible
05.03.2019Amendment by applicant (claims and/or description)
26.06.2019Communication of intention to grant the patent
10.10.2019Fee for grant paid
10.10.2019Fee for publishing/printing paid
10.10.2019Receipt of the translation of the claim(s)
Opposition(s)21.08.2020No opposition filed within time limit [2020/44]
Fees paidRenewal fee
09.01.2019Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU30.01.2017
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MK20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE30.01.2020
LU30.01.2020
BE31.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
[2022/33]
Former [2022/27]HU30.01.2017
AL20.11.2019
AT20.11.2019
CY20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
MT20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
TR20.11.2019
IE30.01.2020
LU30.01.2020
BE31.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2021/10]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
IT20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE30.01.2020
LU30.01.2020
BE31.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2021/08]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
IE30.01.2020
LU30.01.2020
BE31.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/51]AL20.11.2019
AT20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
PL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SI20.11.2019
SK20.11.2019
SM20.11.2019
LU30.01.2020
BE31.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/46]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
LU30.01.2020
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/39]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
MC20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/37]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
SK20.11.2019
SM20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/36]AL20.11.2019
CZ20.11.2019
DK20.11.2019
EE20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
PT12.04.2020
Former [2020/35]AL20.11.2019
CZ20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RO20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/34]AL20.11.2019
ES20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/32]AL20.11.2019
FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/26]FI20.11.2019
HR20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
RS20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/24]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
IS20.03.2020
Former [2020/23]FI20.11.2019
LT20.11.2019
LV20.11.2019
NL20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
GR21.02.2020
Former [2020/22]FI20.11.2019
LT20.11.2019
SE20.11.2019
BG20.02.2020
NO20.02.2020
Former [2020/21]NO20.02.2020
Cited inInternational search[A]WO2009043780  (HOFFMANN LA ROCHE [CH], et al) [A] 1-22 * claims 1-14 * * page 33, lines 10-25 *;
 [A]  - MAVENCAMP T L ET AL, "Synthesis and preliminary pharmacological evaluation of novel derivatives of l-@b-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 16, no. 16, doi:10.1016/J.BMC.2008.07.001, ISSN 0968-0896, (20080815), pages 7740 - 7748, (20080708), XP023904518 [A] 1-22 * abstract * * page 7743; table 2 *

DOI:   http://dx.doi.org/10.1016/j.bmc.2008.07.001
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.